Help Juliette Dietl Fight Glioblastoma

Hope Through a Cutting edge treatment

Juliette, a vibrant young woman in her early twenties, is facing a renewed battle against glioblastoma multiforme (GBM), an aggressive and unforgiving form of brain cancer. Juliette bravely endured chemotherapy, and radiation during her initial diagnosis at just 13 years old. Her family has recently received the devastating news that the cancer has returned.

Unfortunately, standard treatment is no longer recommended in her case and her hope now lies in a promising treatment option that has been conducted in Germany. This cutting-edge treatment has been successful where traditional options have fallen short. It has resulted in several encouraging outcomes, and we are prayerfully seeking the same for Juliette.

This journey will come with challenges. Foremost is a time sensitive financial obstacle. A member of Juliette’s care team introduced us to the CeGaT personalized neoantigen peptide cancer vaccine - a cutting edge, individualized therapy that helps the immune system recognize and attack tumor cells. This innovative treatment is not covered by insurance, so we’re seeking support to make it possible. The cost is nearly $100,000. The deposit of $22,500 has been wired to Germany and genetic sequencing will now be done to determine the peptides used in her vaccine. Then they will require the balance in full before they create the vaccine and administer 14 shots over the course of 10 months, all done in Germany. This innovative treatment can be lifesaving for Juliette.

Thank you in advance for being part of Juliette’s Hope!